| Cat. No. |
Product Name |
Information |
| PC-38053 |
CL2A-SN-38
|
CL2A-SN-38 is a drug-linker conjugate composed of the potent DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to construct antibody drug conjugate (ADC). |
| PC-38052 |
MC-GGFG-DX8951
|
MC-GGFG-DX8951 is a drug-linker conjugate for ADC with antitumor activity by using DX8951 (DNA topoisomerase I inhibitor), linked via the protease cleavable MC-GGFG linker.. |
| PC-38024 |
Mc-MMAF
|
MC-MMAF is a precursor of ADC conjugated MMAF to maleimidocaproyl (mc), MMAF is an antitubulin agent that inhibits cell division by blocking the polymerization of tubulin.. |
| PC-35368 |
Tesirine
|
Tesirine ( SG3249) is a cathepsin B-cleavable valine-alanine pyrrolobenzodiazepine (PBD) dimer as antibody-drug conjugate (ADC) payload. |
| PC-42307 |
SMCC-DM1
|
A thioether linker conjugated with potent microtubule-disrupting agent DM1 (mertansine).. |
| PC-42120 |
Val-Cit-PAB-MMAE
|
A drug-linker conjugate for Antibody-drug conjugates (ADCs) by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the cleavable peptide Val-Cit-PAB.. |
| PC-42200 |
MAL-di-EG-Val-Cit-PAB-MMAE
|
A drug-linker conjugate for antibody-drug conjugate by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the cleavable peptide SuO-Val-Cit-PAB.. |
| PC-42199 |
SuO-Val-Cit-PAB-MMAE
|
A drug-linker conjugate for antibody-drug conjugate by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the cleavable peptide SuO-Val-Cit-PAB.. |
